Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Современная внутриматочная контрацепция
Современная внутриматочная контрацепция
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
В данной статье освещены вопросы актуальности проблем контрацепции и выбора среди современных методов, контролирующих рождаемость. Также обсуждены вопросы механизма противозачаточного действия внутриматочных контрацептивов (ВМК) и эффективности данного вида контрацепции. Приведены рекомендации к назначению и использованию ВМК.
Ключевые слова: контрацепция, внутриматочный контрацептив, механизм противозачаточного действия ВМК, медьсодержащие ВМК, противопоказания к введению ВМК.
Key words: contraception, intrauterine device, mechanism of contraceptive effect of IUD, copper-bearing IUD, contraindications for IUD insertion.
Ключевые слова: контрацепция, внутриматочный контрацептив, механизм противозачаточного действия ВМК, медьсодержащие ВМК, противопоказания к введению ВМК.
________________________________________________
Key words: contraception, intrauterine device, mechanism of contraceptive effect of IUD, copper-bearing IUD, contraindications for IUD insertion.
Полный текст
Список литературы
1. Межевитинова Е.А. Внутриматочная контрацепция. В кн.: Практическая гинекология (Клинические лекции). Под ред. В.И.Кулакова, В.Н.Прилепской. М.: МЕДпрессинформ, 2001; с. 587–601.
2. Population Reference Bureau. Family planning worldwide. 2002 data sheet. http://www.prb.org/Template.cmf?Section=PRB&template=/Content/ContentGroups/Datasheets/Famil...
3. d`Arcanges C. Worldwide use of intrauterine devices for contraception. Contraception 2007; 75: S2–7.
4. Thonneau P, Goulard H, Goyaux N. Risk factors for intrauterine device failure: a review. Contraception 2001; 64: 33–7.
5. Medical Eligibility Criteria for Contraceptive Use Third Edition, WHO, 2004; ISNB 92 4 156266 8 (NLM classification: WP 630).
6. Stefanidis K, Drakakis P, Anastasiadou V et al. Screening and antibiotics before IUD insertion reduced PID. Eur J Contracept Reprod Health Care. Abstr 10th Cohgr Eur Soc Contracept 2008; 13 (2): 139–40.
7. Theodoris T, Zalvanos A, Vavilis D et al. Cu-IUCD and accidental pregnancy. Twenty years experience. Eur J Contracept Reprod Health Care. Abstr 10th Cohgr Eur Soc Contracept 2008; 13 (2): 138.
8. Batar A, Kuukankorpi M, Siljander M et al. Five-year clinical experiences with NovaT380 copper IUD. Contraception 2002; 66: 309–14.
9. Cox M, Tripp S, Blacksell S. Clinical performance of the NovaT380 intrauterine device in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report. J Fam Plan Repr Health Care 2002; 28 (2): 69–72.
10. Kulier R, Helmerhost FM, O`Brien P et al. Copper containing, framed intra-uterine devices for contraception. Cohrane Database Syst Rev 2006; 3: CD005347.
11. French RS, Cowan FM, Mansour D et al. Levonorgestrel-releasing (20 microgram/day) intrauterine system (Mirena) compared with other methods of reversible contraceptive. BJOG 2000; 107: 1218–25.
12. French RS, van Vilet H, Cowan FM et al. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev 2004: CD001776.
13. Avecilla-Palau A, Moreno V. Uterine factors and risk of pregnancy in IUD users: a nested case-control study. Contraception 2003; 67: 33–7.
14. Grimes D. Intrauterine device and upper-genital-tract infection. Lancet 2000; 356: 1013–9.
15. Rodrigues da Cunha A, Dorea JG, Cantuaria A. An intrauterine device and maternal copper metabolism during lactation. Contraception 2001; 63: 37–9.
16. Celen S, Moroy P, Sucak A et al. Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices. Contraception 2004; 69: 279–82.
17. Grimes D, Shulz K, van Vilet H, Stanwood N. Immediate postpartum insertion of intrauterine devices. Cochrane Database Syst Rev 2001; CD003036.
18. Grimes D, Shulz K, Stanwood N. Immediate postabortal insertion of intrauterine devices. Cochrane Database Syst Rev 2004; CD001777.
19. Eroglu K, Akkuzu G, Vural G et al. Comparison of efficacy and complications of IUD insertion in immediate postplacental/early postpartum period with interval period: 1 year follow-up. Contraception 2006; 74: 376–81.
20. Ortyli N, Bulut A, Sahin T, Sivin I. Immediate postabortal contraception with the levonorgestrel intrauterine device, Norplant, and traditional methods. Contraception 2001; 63: 309–14.
21. Pakarinen P, Toivonen J, Luukainen T. Randomized comparison of levonorgestrel- and cooper-releasing intrauterine systems immediately after abortion, with 5 years` follow-up. Contraception 2003; 68: 31–4.
22. Bilian X. Chinese experience with intrauterine devices. Contraception 2007; 75: S31–4.
23. Zhou L, Xiao B. Emergency contraception with multiload Cu-375 SL IUD: a multicenter clinical trial. Contraception 2001; 64: 107–12.
2. Population Reference Bureau. Family planning worldwide. 2002 data sheet. http://www.prb.org/Template.cmf?Section=PRB&template=/Content/ContentGroups/Datasheets/Famil...
3. d`Arcanges C. Worldwide use of intrauterine devices for contraception. Contraception 2007; 75: S2–7.
4. Thonneau P, Goulard H, Goyaux N. Risk factors for intrauterine device failure: a review. Contraception 2001; 64: 33–7.
5. Medical Eligibility Criteria for Contraceptive Use Third Edition, WHO, 2004; ISNB 92 4 156266 8 (NLM classification: WP 630).
6. Stefanidis K, Drakakis P, Anastasiadou V et al. Screening and antibiotics before IUD insertion reduced PID. Eur J Contracept Reprod Health Care. Abstr 10th Cohgr Eur Soc Contracept 2008; 13 (2): 139–40.
7. Theodoris T, Zalvanos A, Vavilis D et al. Cu-IUCD and accidental pregnancy. Twenty years experience. Eur J Contracept Reprod Health Care. Abstr 10th Cohgr Eur Soc Contracept 2008; 13 (2): 138.
8. Batar A, Kuukankorpi M, Siljander M et al. Five-year clinical experiences with NovaT380 copper IUD. Contraception 2002; 66: 309–14.
9. Cox M, Tripp S, Blacksell S. Clinical performance of the NovaT380 intrauterine device in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report. J Fam Plan Repr Health Care 2002; 28 (2): 69–72.
10. Kulier R, Helmerhost FM, O`Brien P et al. Copper containing, framed intra-uterine devices for contraception. Cohrane Database Syst Rev 2006; 3: CD005347.
11. French RS, Cowan FM, Mansour D et al. Levonorgestrel-releasing (20 microgram/day) intrauterine system (Mirena) compared with other methods of reversible contraceptive. BJOG 2000; 107: 1218–25.
12. French RS, van Vilet H, Cowan FM et al. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev 2004: CD001776.
13. Avecilla-Palau A, Moreno V. Uterine factors and risk of pregnancy in IUD users: a nested case-control study. Contraception 2003; 67: 33–7.
14. Grimes D. Intrauterine device and upper-genital-tract infection. Lancet 2000; 356: 1013–9.
15. Rodrigues da Cunha A, Dorea JG, Cantuaria A. An intrauterine device and maternal copper metabolism during lactation. Contraception 2001; 63: 37–9.
16. Celen S, Moroy P, Sucak A et al. Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices. Contraception 2004; 69: 279–82.
17. Grimes D, Shulz K, van Vilet H, Stanwood N. Immediate postpartum insertion of intrauterine devices. Cochrane Database Syst Rev 2001; CD003036.
18. Grimes D, Shulz K, Stanwood N. Immediate postabortal insertion of intrauterine devices. Cochrane Database Syst Rev 2004; CD001777.
19. Eroglu K, Akkuzu G, Vural G et al. Comparison of efficacy and complications of IUD insertion in immediate postplacental/early postpartum period with interval period: 1 year follow-up. Contraception 2006; 74: 376–81.
20. Ortyli N, Bulut A, Sahin T, Sivin I. Immediate postabortal contraception with the levonorgestrel intrauterine device, Norplant, and traditional methods. Contraception 2001; 63: 309–14.
21. Pakarinen P, Toivonen J, Luukainen T. Randomized comparison of levonorgestrel- and cooper-releasing intrauterine systems immediately after abortion, with 5 years` follow-up. Contraception 2003; 68: 31–4.
22. Bilian X. Chinese experience with intrauterine devices. Contraception 2007; 75: S31–4.
23. Zhou L, Xiao B. Emergency contraception with multiload Cu-375 SL IUD: a multicenter clinical trial. Contraception 2001; 64: 107–12.
2. Population Reference Bureau. Family planning worldwide. 2002 data sheet. http://www.prb.org/Template.cmf?Section=PRB&template=/Content/ContentGroups/Datasheets/Famil...
3. d`Arcanges C. Worldwide use of intrauterine devices for contraception. Contraception 2007; 75: S2–7.
4. Thonneau P, Goulard H, Goyaux N. Risk factors for intrauterine device failure: a review. Contraception 2001; 64: 33–7.
5. Medical Eligibility Criteria for Contraceptive Use Third Edition, WHO, 2004; ISNB 92 4 156266 8 (NLM classification: WP 630).
6. Stefanidis K, Drakakis P, Anastasiadou V et al. Screening and antibiotics before IUD insertion reduced PID. Eur J Contracept Reprod Health Care. Abstr 10th Cohgr Eur Soc Contracept 2008; 13 (2): 139–40.
7. Theodoris T, Zalvanos A, Vavilis D et al. Cu-IUCD and accidental pregnancy. Twenty years experience. Eur J Contracept Reprod Health Care. Abstr 10th Cohgr Eur Soc Contracept 2008; 13 (2): 138.
8. Batar A, Kuukankorpi M, Siljander M et al. Five-year clinical experiences with NovaT380 copper IUD. Contraception 2002; 66: 309–14.
9. Cox M, Tripp S, Blacksell S. Clinical performance of the NovaT380 intrauterine device in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report. J Fam Plan Repr Health Care 2002; 28 (2): 69–72.
10. Kulier R, Helmerhost FM, O`Brien P et al. Copper containing, framed intra-uterine devices for contraception. Cohrane Database Syst Rev 2006; 3: CD005347.
11. French RS, Cowan FM, Mansour D et al. Levonorgestrel-releasing (20 microgram/day) intrauterine system (Mirena) compared with other methods of reversible contraceptive. BJOG 2000; 107: 1218–25.
12. French RS, van Vilet H, Cowan FM et al. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev 2004: CD001776.
13. Avecilla-Palau A, Moreno V. Uterine factors and risk of pregnancy in IUD users: a nested case-control study. Contraception 2003; 67: 33–7.
14. Grimes D. Intrauterine device and upper-genital-tract infection. Lancet 2000; 356: 1013–9.
15. Rodrigues da Cunha A, Dorea JG, Cantuaria A. An intrauterine device and maternal copper metabolism during lactation. Contraception 2001; 63: 37–9.
16. Celen S, Moroy P, Sucak A et al. Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices. Contraception 2004; 69: 279–82.
17. Grimes D, Shulz K, van Vilet H, Stanwood N. Immediate postpartum insertion of intrauterine devices. Cochrane Database Syst Rev 2001; CD003036.
18. Grimes D, Shulz K, Stanwood N. Immediate postabortal insertion of intrauterine devices. Cochrane Database Syst Rev 2004; CD001777.
19. Eroglu K, Akkuzu G, Vural G et al. Comparison of efficacy and complications of IUD insertion in immediate postplacental/early postpartum period with interval period: 1 year follow-up. Contraception 2006; 74: 376–81.
20. Ortyli N, Bulut A, Sahin T, Sivin I. Immediate postabortal contraception with the levonorgestrel intrauterine device, Norplant, and traditional methods. Contraception 2001; 63: 309–14.
21. Pakarinen P, Toivonen J, Luukainen T. Randomized comparison of levonorgestrel- and cooper-releasing intrauterine systems immediately after abortion, with 5 years` follow-up. Contraception 2003; 68: 31–4.
22. Bilian X. Chinese experience with intrauterine devices. Contraception 2007; 75: S31–4.
23. Zhou L, Xiao B. Emergency contraception with multiload Cu-375 SL IUD: a multicenter clinical trial. Contraception 2001; 64: 107–12.
________________________________________________
2. Population Reference Bureau. Family planning worldwide. 2002 data sheet. http://www.prb.org/Template.cmf?Section=PRB&template=/Content/ContentGroups/Datasheets/Famil...
3. d`Arcanges C. Worldwide use of intrauterine devices for contraception. Contraception 2007; 75: S2–7.
4. Thonneau P, Goulard H, Goyaux N. Risk factors for intrauterine device failure: a review. Contraception 2001; 64: 33–7.
5. Medical Eligibility Criteria for Contraceptive Use Third Edition, WHO, 2004; ISNB 92 4 156266 8 (NLM classification: WP 630).
6. Stefanidis K, Drakakis P, Anastasiadou V et al. Screening and antibiotics before IUD insertion reduced PID. Eur J Contracept Reprod Health Care. Abstr 10th Cohgr Eur Soc Contracept 2008; 13 (2): 139–40.
7. Theodoris T, Zalvanos A, Vavilis D et al. Cu-IUCD and accidental pregnancy. Twenty years experience. Eur J Contracept Reprod Health Care. Abstr 10th Cohgr Eur Soc Contracept 2008; 13 (2): 138.
8. Batar A, Kuukankorpi M, Siljander M et al. Five-year clinical experiences with NovaT380 copper IUD. Contraception 2002; 66: 309–14.
9. Cox M, Tripp S, Blacksell S. Clinical performance of the NovaT380 intrauterine device in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report. J Fam Plan Repr Health Care 2002; 28 (2): 69–72.
10. Kulier R, Helmerhost FM, O`Brien P et al. Copper containing, framed intra-uterine devices for contraception. Cohrane Database Syst Rev 2006; 3: CD005347.
11. French RS, Cowan FM, Mansour D et al. Levonorgestrel-releasing (20 microgram/day) intrauterine system (Mirena) compared with other methods of reversible contraceptive. BJOG 2000; 107: 1218–25.
12. French RS, van Vilet H, Cowan FM et al. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev 2004: CD001776.
13. Avecilla-Palau A, Moreno V. Uterine factors and risk of pregnancy in IUD users: a nested case-control study. Contraception 2003; 67: 33–7.
14. Grimes D. Intrauterine device and upper-genital-tract infection. Lancet 2000; 356: 1013–9.
15. Rodrigues da Cunha A, Dorea JG, Cantuaria A. An intrauterine device and maternal copper metabolism during lactation. Contraception 2001; 63: 37–9.
16. Celen S, Moroy P, Sucak A et al. Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices. Contraception 2004; 69: 279–82.
17. Grimes D, Shulz K, van Vilet H, Stanwood N. Immediate postpartum insertion of intrauterine devices. Cochrane Database Syst Rev 2001; CD003036.
18. Grimes D, Shulz K, Stanwood N. Immediate postabortal insertion of intrauterine devices. Cochrane Database Syst Rev 2004; CD001777.
19. Eroglu K, Akkuzu G, Vural G et al. Comparison of efficacy and complications of IUD insertion in immediate postplacental/early postpartum period with interval period: 1 year follow-up. Contraception 2006; 74: 376–81.
20. Ortyli N, Bulut A, Sahin T, Sivin I. Immediate postabortal contraception with the levonorgestrel intrauterine device, Norplant, and traditional methods. Contraception 2001; 63: 309–14.
21. Pakarinen P, Toivonen J, Luukainen T. Randomized comparison of levonorgestrel- and cooper-releasing intrauterine systems immediately after abortion, with 5 years` follow-up. Contraception 2003; 68: 31–4.
22. Bilian X. Chinese experience with intrauterine devices. Contraception 2007; 75: S31–4.
23. Zhou L, Xiao B. Emergency contraception with multiload Cu-375 SL IUD: a multicenter clinical trial. Contraception 2001; 64: 107–12.
Авторы
И.В.Кузнецова
Кафедра акушерства и гинекологии РМАПО, Москва
Кафедра акушерства и гинекологии РМАПО, Москва
________________________________________________
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.